Dr Anisa Choudhary MPharm, AFHEA, PhD

Dr Anisa Choudhary

School of Pharmacy
Lecturer in Clinical Pharmacy & Clinical Pharmacology

Contact details

Email
a.choudhary.1@bham.ac.uk
View my research portal
Address
Robert Aitken Building
School of Pharmacy
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Anisa is a Lecturer in Clinical Pharmacy & Clinical Pharmacology and has a range of experience teaching at both undergraduate and postgraduate level.

Anisa completed her PhD at Barts and The London School of Medicine and Dentistry, Queen Mary University of London. Her research focuses on phenotyping patients with overlap irritable bowel syndrome and hypermobile Ehlers-Danlos syndrome.

ResearchGate profile

Qualifications

  • PhD in Neurogastroenterology 2022
  • AFHEA, Higher Education Academy, 2021
  • MPharm, University of Bradford, 2016

Biography

Anisa gained a Masters in Pharmacy (Hons) from the University of Bradford in 2016. After registration as a Pharmacist, Anisa obtained a range of experience in both community and hospital pharmacy sites across the North West. In 2018 Anisa went on to pursue a PhD at Barts and The London School of Medicine and Dentistry, Queen Mary University of London.

Anisa’s PhD aimed to phenotype patients with overlap irritable bowel syndrome and hypermobile Ehlers-Danlos syndrome through symptomatic, physiological and molecular profiling. She received the Young Investigator Award from the European Society of Neurogastroenterology and Motility for her research in this field.

Alongside her PhD, Anisa taught and led the therapeutic pharmacology curriculum on the Physicians Associate MSc at Queen Mary University of London.

In October 2021, Anisa joined the College of Medicine and Health as Lecturer in Clinical Pharmacy & Pharmacology.

Teaching

  • Clinical Pharmacy & Clinical Pharmacology
  • Health, disease & therapeutics 

Research

Research interests
Anisa’s main research interests include:

  • Functional and organic gastrointestinal disorders
  • Phenotyping of patients with Irritable Bowel Syndrome
  • The relevance of gut-brain interactions in providing and developing pharmacological interventions

Publications

Choudhary, A., 2022. Comorbid Irritable Bowel Syndrome and Hypermobile Ehlers-Danlos Syndrome: An unexplored Phenotype.

Fikree, A., Vollebregt, P.F., Choudhary, A., Aziz, Q. and Scott, S.M., 2022. rectal hyposensitivity in patients with hypermobile E hlers‐D anlos syndrome and constipation—authors' reply. Alimentary Pharmacology & Therapeutics, 56(5), pp.907-908.

Choudhary, A., Vollebregt, P.F., Aziz, Q., Scott, S.M. and Fikree, A., 2022. Rectal hyposensitivity: a common pathophysiological finding in patients with constipation and associated hypermobile Ehlers–Danlos syndrome. Alimentary pharmacology & therapeutics, 56(5), pp.802-813.

Choudhary, A., Fikree, A. and Aziz, Q., 2022. Tu1359: Overlap of IBS and hEDS/HSD: A Phenotype Characterised by marked autonomic symptoms and increased prevalence of chronic pain. Gastroenterology, 162(7), pp.S-932.

Choudhary, A., Fikree, A., Aziz, Q. (2021). Overlap between Irritable Bowel Syndrome and Hypermobile Ehlers-Danlos Syndrome: An unexplored clinical phenotype? American Journal of Medical Genetics Part C: Seminars in Medical Genetics. doi: 10.1002/ajmg.c.31938

Choudhary, A., Rashed, S., Upadhyaya, A., Fikree, A., & Aziz, Q. (2021). PWE-66 Comorbid Irritable Bowel Syndrome and Hypermobile Ehlers-Danlos Syndrome: A distinct clinical phenotype? Gut 70 (Suppl 4):A177.1-A177. doi:10.1136/gutjnl-2021-bsg.328

Choudhary, A., Rashed, S., Upadhyaya, A., Fikree, A., Aziz, Q., (2021). NGS15510-84 Differences in symptomatic and autonomic profiles in co-morbid irritable bowel syndrome and hypermobile Ehlers-Danlos syndrome vs. irritable bowel syndrome alone. Neurogastroenterology & Motility; Volume 33, Issue S2. https://doi.org/10.1111/nmo.14244

Choudhary, A., Fikree, A., Aziz, I., Palsson, O., Q, Aziz., (2021). P0596 Characterising psychomorbidity and quality of life in patients with hypermobile Ehlers-Danlos syndrome stratified according to functional gastrointestinal disease. United European Gastroenterology Journal 2021; 9 (Supplement 1) https://doi.org/10.1002/ueg2.12144

Choudhary, A., Fikree, A., Scott, S.M., Aziz, Q., Aktar, R., (2020). 2021. 060 Altered colonic neuroinflammatory profile in Irritable Bowel Syndrome with and without hypermobile Ehlers Danlos Syndrome. Gut, 2021;70:A33 -A34

Choudhary, A., Fikree, A., Scott, S.M., Aziz, Q., Aktar, R., (2020). P0747 Mast cells and enteric nerve changes in Irritable Bowel Syndrome patients with and without hypermobile Ehlers-Danlos Syndrome. United European Gastroenterology Journal 2020; 8 (Supplement 1) https://doi.org/10.1177/2050640620927345

Choudhary, A., Vollebregt, P., Aziz, Q., Scott, S.M. Fikree, A., (2020). P0750 Rectal Hyposensitivity: A common pathophysiological finding in patients with Hypermobile Ehlers-Danlos Syndrome. United European Gastroenterology Journal 2020; 8 (Supplement 1) https://doi.org/10.1177/2050640620927345

View all publications in research portal